Aarkstore Enterprise---oxis International, Inc. (oxis) - Financial And Strategic Analysis Review

Oxis International, Inc

Oxis International, Inc. (OXIS) is principally engaged in the research and development of neutraceutical products for sale to general consumers. The companys main divisions are Ergothioneine and Therapeutics. It owns Biocheck, a provider of enzyme immunoassay research services and products in the immunoassay segment of the clinical diagnostics market. Its research and development activities are principally into patent development and other research programs and projects. The company operates in the US, Canada, Mexico, Europe, Middle East, Africa, Asia Pacific and Other Countries. It has two subsidiaries namely, BioCheck, Inc. and OXIS Therapeutics, Inc.

OXIS International, Inc. Key Recent Developments

Aug 24, 2010 OXIS To Introduce New Ergothioneine-Based Supplements For Joint Health And Healthy Aging

Jun 23, 2010 OXIS Appoints of Okezie Aruoma As President Of Scientific Advisory Board

Jun 14, 2010 OXIS Appoints Thomas Hoog To Board

Mar 05, 2010 Oxis International Announces Board Changes

This comprehensive SWOT profile of OXIS International, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company

For more information please contact :

http://www.aarkstore.com/reports/OXIS-International-Inc-OXIS-Financial-and-Strategic-Analysis-Review-62765.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise---sequenom, Inc. (sqnm) - Financial And Strategic Analysis Review Aarkstore Enterprise---patterson Companies, Inc. (pdco) - Financial And Strategic Analysis Review Aarkstore Enterprise---biotest Ag (bio3) - Financial And Strategic Analysis Review Aarkstore Enterprise---unicharm Corporation (8113) - Financial And Strategic Analysis Review Aarkstore Enterprise---medassets, Inc. (mdas) - Financial And Strategic Analysis Review Aarkstore Enterprise---onex Corporation (ocx) - Financial And Strategic Analysis Review Aarkstore Enterprise---beiersdorf Ag (bei) - Financial And Strategic Analysis Review Aarkstore Enterprise---avery Dennison Corporation (avy) - Financial And Strategic Analysis Review Aarkstore Enterprise---endologix, Inc. (elgx) - Financial And Strategic Analysis Review Aarkstore Enterprise---ion Beam Applications S.a. (ibab) - Financial And Strategic Analysis Review Aarkstore Enterprise---konica Minolta Holdings, Inc. (4902) - Financial And Strategic Analysis Revie Aarkstore Enterprise---synergetics Usa, Inc. (surg) - Financial And Strategic Analysis Review Aarkstore Enterprise---thermogenesis Corp. (kool) - Financial And Strategic Analysis Review